Quadria Capital invests $70 million in New Delhi-based Akums Drugs2 min read 08 Dec 2019, 10:35 PM IST
Akums will use the capital to fund its growth strategy and inorganic opportunities, said co-founder Sanjeev Jain
General Atlantic bought the stake from PE firm Everstone and other shareholders
Quadria Capital, a healthcare-focused private equity firm, has invested $70 million into Akums Drugs & Pharmaceuticals Ltd, a New Delhi-based pharmaceuticals contract research and manufacturing services provider, two people aware of the development said, requesting anonymity.
Select your Category